InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by KANGO SUJAY, Directeur Exécutif. Officer active across 1 company, notably Acceleron Pharma INC. In total, 8 reports have been published. Activity tracked since 12 February 2021. The latest transaction was disclosed on 27 September 2021 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
18,509 sharesCommon StockSEC:0001104659-21-142269:0
18,509 sharesCommon StockSEC:0001104659-21-142269
5,000 shares@ US$40.6119.6% of flowCommon StockSEC:0001179110-21-008949:0
5,000 shares@ US$40.6119.6% of flowCommon StockSEC:0001179110-21-008949
5,000 shares@ US$40.6119.6% of flowCommon StockSEC:0001179110-21-008894:0
5,000 shares@ US$40.6119.6% of flowCommon StockSEC:0001179110-21-008894
887 shares@ US$130.8710.8% of flowCommon StockSEC:0001179110-21-006494:0
887 shares@ US$130.8710.8% of flowCommon StockSEC:0001179110-21-006494
8 of 8 declarations
About KANGO SUJAY
Sujay Kango is the Executive Vice President and Chief Commercial Officer at Acceleron Pharma Inc. He is responsible for commercial strategy and operations management. His expertise in the pharmaceutical sector helps guide growth and innovation initiatives.
